Lenvima and Mycophenolate Tablets Delayed Release

• Generic Name: lenvatinib
• Dosage Forms: capsule
• Other Brand Names: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose

Lenvima (lenvatinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Lenvima is used to treat thyroid cancer. It is usually given after radioactive iodine has been tried without success.

Lenvima is used together with everolimus (Afinitor) to treat advanced kidney cancer when other medicines have not been effective.

Lenvima is used alone to treat liver cancer that cannot be removed with surgery.

Lenvima is used together with pembrolizumab (Keytruda) to treat a certain type of endometrial cancer (a type of uterine cancer) that has progressed and cannot be removed with surgery or radiation.

• Generic Name: mycophenolic acid
• Dosage Forms: tablet, delayed release
• Other Brand Names: Myfortic

Mycophenolic acid weakens your body's immune system, to help keep it from "rejecting" a transplanted organ such as a kidney. Organ rejection happens when the immune system treats the new organ as an invader and attacks it.

Mycophenolic acid is used with other medicines to prevent organ rejection after a kidney transplant.

Mycophenolic acid may also be used for purposes not listed in this medication guide.